From June 2023, two products have been added to the list of HRT medicines covered by the new HRT prepayment certificate (HRT PPC). The additions are:

• Tibolone 2.5mg tablets (Livial)
• Prasterone 6.5mg pessaries (Intrarosa)

The June 2023 Drug Tariff (Part XVI) has been updated to include these additional HRT medicines. The updated of definition of HRT reads:

Hormone Replacement Therapy (HRT) is the replacement of female sex hormones oestrogen and progesterone in women to control symptoms of the menopause. Some medicines that are converted or break down into oestrogen, progestogen or androgen hormones are prescribed for relief of menopausal symptoms. For the purposes of the HRT PPC these are included within this definition of HRT. Types of HRT include:

• combined oestrogen plus progestogen HRT – for women who still have their uterus
• oestrogen only HRT – for women who have had a hysterectomy
• tibolone – acts as a combined hormone therapy.

 Dispensers are advised to check the list of HRT medicines covered by the HRT PPC on the NHSBSA website.